Common causes of vision loss in elderly patients

American Family Physician

Volumn 60, Issue 1, 1999, Pages 99-108

  Quillen, David A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIPIVEFRINE; DORZOLAMIDE; FLUOROURACIL; GLYCEROL; ISOSORBIDE; LATANOPROST; LEVOBUNOLOL; MANNITOL; METHAZOLAMIDE; METIPRANOLOL; MITOMYCIN C; PILOCARPINE; PILOPINE HS; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SUXAMETHONIUM; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

AGED; AGING; CATARACT; CLINICAL FEATURE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE LESION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; VISION TEST; VISUAL FIELD; VISUAL IMPAIRMENT;

AGE FACTORS; AGED; CATARACT; DIABETIC RETINOPATHY; DIAGNOSIS, DIFFERENTIAL; GLAUCOMA; HUMANS; MACULAR DEGENERATION; RISK FACTORS; VISION DISORDERS;

EID: 0345643490     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Ganley JP, Roberts J, eds. Eye conditions and related need for medical care among persons 1-74 years of age, United States, 1971-72. Hyattsville, Md.: U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics, 1983; DHHS publication no. 83-1678.
2. Shmuely-Dulitzki Y, Rovner BW. Screening for depression in older persons with low vision. Somatic eye symptoms and the Geriatric Depression Scale. Am J Geriatr Psychiatry 1997;5:216-20.
3. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-8.
4. Hyman L. Epidemiology of eye disease in the elderly. Eye 1987;1(pt 2):330-41.
5. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272:1413-20.
6. Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998;82:907-10.
7. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol 1988;106:192-8.
8. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, et al. Are antioxidants or supplements protective for age-rated macular degeneration? Arch Ophthalmol 1994;112:222-7.
9. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol 1993;111:104-9.
10. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62 (6suppl):1448S-61S.
11. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141-6.
12. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998;42:535-47.
13. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110:1701-8.
14. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1991;109:1109-14.
15. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 1998;43:134-46.
16. Pizzarello LD. The dimensions of the problem of eye disease among the elderly. Ophthalmology 1987;94:1191-5.
17. Palmberg P. A topical carbonic anhydrase inhibitor finally arrives [Editorial]. Arch Ophthalmol 1995: 113:985-6.
18. Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. Int Ophthalmol 1990;14:135-40.
19. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
20. West SK, Duncan DD, Munoz B, Rubin GS, Fried LP, Bandeen-Roche K, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project. JAMA 1998;280:714-8.
21. Learning DV. Practice styles and preferences of 4 ASCRS members - 1994 survey. J Cataract Refract Surg 1995;21:378-85.
22. Leen MM, Ho CC, Yanoff M. Association between surgically induced astigmatism and cataract incision size in the early postoperative period. Ophthalmic Surgery 1993;24:586-92.
23. Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987; 27:230-8.
24. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
25. Molyneaux LM, Constantino MI, McGill M, Zilkens R, Yue DK. Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetics: comparison with the DCCT. Diabetes Res Clin Pract 1998;42:77-83.
26. Neely KA, Quillen DA, Schachat AR Gardner TW, Blankenship GW. Diabetic retinopathy. Med Clin North Am 1998;82:847-76.
27. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976;81:383-96.
28. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806